Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Disruption of major Ptchd1 isoforms causes autistic traits in social behavior and communication.

Molecular psychiatry·2026

Same author

Genetically prioritized druggable targets for amyloid-β pathology highlight <i>ACE</i> as a therapeutic candidate in Alzheimer's disease.

Journal of Alzheimer's disease : JAD·2026

Same author

MeCP2 NID interaction with RNA: implications for Rett syndrome-relevant protein regulation.

Human molecular genetics·2026

Same author

Autism spectrum disorder trios from consanguineous populations are enriched for rare homozygous variants, identifying 32 new candidate genes.

Scientific reports·2026

Same author

Trajectory of skill acquisition, loss, and regain in females with classic Rett syndrome.

Journal of neurodevelopmental disorders·2026

Same author

Genetic architecture of plasma pTau217 and related biomarkers in Alzheimer's disease via genome-wide association studies.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Same journal

Circulating MYOM3 fragments reflect disease severity and therapeutic efficacy in tubular aggregate myopathy and Stormorken syndrome.

Human molecular genetics·2026

Same journal

The FVB-nmd SMARD1 mouse presents with early respiratory deficits and pathology that significantly impact lifespan.

Human molecular genetics·2026

Same journal

Utrophin requires α-Syntrophin to maintain neuromuscular junction integrity in mdx mice.

Human molecular genetics·2026

Same journal

A novel gene ACTRT3 mutations induce sperm malformations and fertilization failure via Acrosomal ultrastructural defects.

Human molecular genetics·2026

Same journal

Nucleic acid-based therapeutic strategies for modulator-refractory cystic fibrosis-causing variants.

Human molecular genetics·2026

Same journal

Evidence that disruption of Discoidin domain receptor 2 contributes to palate malformations through effects on the extracellular matrix.

Human molecular genetics·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 17, 2025

A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome

A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome

Published on: May 22, 2019

Testing the PEST hypothesis using relevant Rett mutations in MeCP2 E1 and E2 isoforms.

Ladan Kalani¹, Bo-Hyun Kim¹, Alberto Ruiz de Chavez²

¹Department of Biochemistry and Microbiology, University of Victoria, 3800 Finnerty Rd, Victoria, BC V8W 2Y2, Canada.

Human Molecular Genetics

|August 13, 2024

Summary

This summary is machine-generated.

Mutations in methyl-CpG binding protein 2 (MeCP2) impact protein levels, affecting Rett syndrome (RTT) pathogenesis. Different mutations cause varied MeCP2 expression changes, influencing cellular mechanisms.

Keywords:

MeCP2 PEST sequences Rett chromatin methyl CpG binding protein

More Related Videos

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants

Published on: May 22, 2020

Pooled shRNA Screen for Reactivation of MeCP2 on the Inactive X Chromosome

Pooled shRNA Screen for Reactivation of MeCP2 on the Inactive X Chromosome

Published on: March 2, 2018

Related Experiment Videos

Last Updated: Jun 17, 2025

A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome

A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome

Published on: May 22, 2019

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants

Published on: May 22, 2020

Pooled shRNA Screen for Reactivation of MeCP2 on the Inactive X Chromosome

Pooled shRNA Screen for Reactivation of MeCP2 on the Inactive X Chromosome

Published on: March 2, 2018

Area of Science:

Neuroscience
Molecular Biology
Genetics

Background:

Mutations in methyl-CpG binding protein 2 (MeCP2) are the primary cause of Rett syndrome (RTT).
Observed alterations in MeCP2 protein expression and nuclear size changes lack detailed molecular understanding.
The study investigates the impact of specific MeCP2 mutations on protein levels and cellular function.

Purpose of the Study:

To quantify MeCP2 protein level changes caused by specific RTT-associated mutations (T158M, P152R, R294X, R306C).
To explore the role of MeCP2 PEST domains in proteasomal degradation.
To investigate the R294X mutant's effect on MeCP2 and histone H1 competition at chromatin.

Main Methods:

Utilized a C2C12 cellular system expressing human MeCP2-E1.
Employed mouse models carrying specific MeCP2 mutations.
Analyzed MeCP2 protein expression levels and isoform-specific changes.

Main Results:

T158M and P152R mutations decreased MeCP2 protein levels.
R306C showed minor variations, while R294X increased MeCP2 protein 2.5-3 fold.
The R294X mutation differentially affected MeCP2 E1 (increased) and E2 (decreased) isoforms, suggesting distinct regulatory mechanisms.

Conclusions:

MeCP2 mutation-specific alterations in protein levels are demonstrated.
The study provides insights into MeCP2 regulation, including potential PEST domain involvement and isoform-specific dynamics.
Findings contribute to understanding the molecular basis of Rett syndrome pathogenesis.